- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 14, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Becker’s GI & Endoscopy referenced a study published in the April 2024 issue of The American Journal of Managed Care® (AJMC®). The article, “Prices and Complications in Hospital-Based and Freestanding Surgery Centers,” found that although the average prices were substantially higher in hospital-based surgery centers, freestanding surgery centers had similar rates of complications for colonoscopy, arthroscopy, and cataract removal.
A study published in the special Health IT issue of AJMC, entitled, “Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs,” was referenced in an article published by mHealthIntelligence. The study found that virtual-first care had potential long-term health and financial implications when used to prevent and manage cardiometabolic chronic conditions.
In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy
August 15th 2025Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression after CAR T-cell therapy, highlighting treatment challenges and outcomes.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?
August 15th 2025Identifying specific biomarkers and clinical characteristics is crucial for predicting a patient's response to both existing and emerging treatments for chronic spontaneous urticaria, thereby moving toward a more personalized approach to care.
Read More
Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA
August 15th 2025Children with spinal muscular atrophy (SMA) showed motor function improvements after switching to onasemnogene abeparvovec following prior treatment with nusinersen or risdiplam in a real-world study.
Read More
